• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

Analysis of the function of membrane TNF-α

Research Project

Project/Area Number 14570418
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内科学一般
Research InstitutionKyushu University

Principal Investigator

HORIUCHI Takahiko  Kyushu University Hospital, Assistant Professor, 大学病院, 講師 (90219212)

Co-Investigator(Kenkyū-buntansha) TSUKAMOTO Hiroshi  Kyushu University Hospital, Research Associate, 大学病院, 助手 (70304772)
Project Period (FY) 2002 – 2003
Keywordscytokine / anti-TNF-αtherapy / Crohn's disease / Rheumatoid arthritis
Research Abstract

TNF-□ antagonists are the. center of attention for their dramatic clinical efficacy in active chronic inflammatory diseases. In rheumatoid arthritis, both infliximab (chimeric anti-TNF-□ antibody) and etanercept(p75 TNF-□ receptor fusion protein) are highly effective while in Crohn's disease, only infliximab can induce clinical remission. As the differential clinical efficacy was likely to be caused by biological effects other than mere neutralization of soluble TNF-□, we here investigated reverse signaling through transmembrane TNF-□mTNF) induced by these drugs. Both infliximab and etanercept induced E-selectin expression on human Jurkat T cells stably transfected with mTNF, however only infliximab was able to induce IL-10 production, apoptosis, ROS accumulation and G1 cell cycle arrest. We next examined the element of the mTNF essential for these biological effects induced by infliximab. Cytoplasmic serine residues at positions 2,5 and 27 of mTNF were sequentially substituted to alanine by site-directed mutagenesis. Infliximab-induced apoptosis and cell cycle arrest were completely abrogated by substitution of all of these three cytoplasmic serine residues. In this study, we revealed that novel biological effects induced by infliximab and etanercept were mediated by reverse signaling of mTNF, which might explain the differential clinical efficacy of these anti-TNF-□ agents. We also clarified that cytoplasmic serine residues were critical for the signal transduction through mTNF.

  • Research Products

    (10 results)

All Other

All Publications (10 results)

  • [Publications] Sawabe T, Horiuchi T, et al.: "Aberrant HS-1 molecule in a patient with systemic lupus erythematosus"Genes Immun.. 4(2). 122-131 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koyama T, Tsukamoto H, et al.: "Novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus"Rheumatology. 42. 980-985 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Harashima S, Tsukamoto H, et al.: "Successful treatment of invasive pulmonary aspergillosis by transbronchial injection of urinary trypsin inhibitor and amphotericin B"Acta Haematol. 109. 156-157 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Harashima S, Tsukamoto H, et al.: "Osteoprotegerin and receptor activator of nuclear factor kBligand expression in fibroblast-like synoviocytes from RA and patients"Rheumatology. 43. 396-397 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Mitoma H, Horiuchi T, et al.: "Binding activities of infliximab and etanercept to transmembrane tumor necrosis factor-α"Gastroenterology. 126(3). 934-935 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sawabe T, Horiuchi T, Koga R, Tsukamoto H, Kojima T, Harashima S, Kikuchi Y, Niho Y, Watanabe T.: "Aberrant HS1 molecule in a patient with systemic lupus erythematosus."Genes Immun.. 4(2). 122-131 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koyama T, Tsukamoto H, Masumoto K, Himeji D, Hayashi K, Harada M, Horiuchi T.: "A novel polymorphism of human APRIL gene is associated with systemic lupus erythematosus."Rheumatology. 42. 980-985 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Harashima S, Tsukamoto H, Otsuka J, Horiuchi T.: "Successful treatment of invasive pulmonary aspergillosis by transbronchial injection of urinary trypsin inhibitor and amphotericin B"Acta Haematol.. 109. 156-157 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Harashima S, Tsukamoto H, Horiuchi T.: "Osteoprotegerin and receptor activator for nuclear factor κB ligand expression in fibroblast-like synoviocytes from rheumatoid arthritis and osteoarthritis patients."Rheumatology. 43. 396-397 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mitoma H, Horiuchi T, Tsukamoto H.: "Binding activities of infliximab and etanercept to transmembrane tumor necrosis factor (TNF)-□."Gastroenterology. 126(3). 934-935 (2004)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi